Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 1/2024

01-01-2024 | Correction

Correction to: Cardiometabolic comorbidities in Hispanic/Latino cancer survivors: prevalence and impact on health‑related quality of life and supportive care needs

Authors: Ashley F. Maras, Frank J. Penedo, Amelie G. Ramirez, Sarah M. Worch, Manuel S. Ortiz, Betina Yanez, Edgar Munoz, Thomas Lad, Courtney Hollowell, Heidy N. Medina, Patricia I. Moreno

Published in: Supportive Care in Cancer | Issue 1/2024

Login to get access

Excerpt

Correction to: Supportive Care in Cancer …
Metadata
Title
Correction to: Cardiometabolic comorbidities in Hispanic/Latino cancer survivors: prevalence and impact on health‑related quality of life and supportive care needs
Authors
Ashley F. Maras
Frank J. Penedo
Amelie G. Ramirez
Sarah M. Worch
Manuel S. Ortiz
Betina Yanez
Edgar Munoz
Thomas Lad
Courtney Hollowell
Heidy N. Medina
Patricia I. Moreno
Publication date
01-01-2024
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2024
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-023-08217-0

Other articles of this Issue 1/2024

Supportive Care in Cancer 1/2024 Go to the issue

Research

The feasibility of a multidimensional intervention in lymphoma survivors with chronic fatigue

Comment

Characterization of dysgeusia and xerostomia in patients with multiple myeloma treated with the T-cell redirecting GPRC5D bispecific antibody talquetamab

Research

The views of parents of children with cancer and pediatric physical therapists on a network for continuity and optimal quality of care for children with cancer: KinderOncoNet

Research

Prediction of gastrointestinal symptoms trajectories using omega-3 and inflammatory biomarkers in early-stage breast cancer patients receiving chemotherapy

Special Section

2023 Updated MASCC/ESMO Consensus Recommendations: prevention of radiotherapy- and chemoradiotherapy-induced nausea and vomiting

Review

Interventions to improve quality of life in patients with head and neck cancers receiving radiation therapy: a scoping review
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits